Amicus Therapeutics, Inc.
US ˙ NasdaqGM ˙ US03152W1099
TEN SYMBOL NIE JEST JUŻ AKTYWNY

SecurityFOLD / Amicus Therapeutics, Inc.
InstitutionNorthern Trust Corp
Latest Disclosed Ownership2,720,444 shares
Latest Disclosed Value $ 39,337,619
Northern Trust Corp reports 2.88% increase in ownership of FOLD / Amicus Therapeutics, Inc.

On May 14, 2026 - Northern Trust Corp filed a 13F-HR form disclosing ownership of 2,720,444 shares of Amicus Therapeutics, Inc. (US:FOLD) valued at $39,337,620 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 2,644,213 shares of Amicus Therapeutics, Inc.. This represents a change in shares of 2.88% during the quarter. The current value of the position is $39,419,234 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F AMICUS THERAPEUTIC COM 03152W109 2,720,444 76,231 2.88 39,338 4.47 0.0011
2026-02-17 2025-12-31 13F AMICUS THERAPEUTICS COM 03152W109 2,644,213 -693,162 -20.77 37,654 43.18 0.0048
2025-11-14 2025-09-30 13F AMICUS THERAPEUTICS COM 03152W109 3,337,375 247,569 8.01 26,299 48.54 0.0034
2025-08-13 2025-06-30 13F AMICUS THERAPEUTICS COM 03152W109 3,089,806 -285,320 -8.45 17,705 -35.72 0.0024
2025-05-13 2025-03-31 13F AMICUS THERAPEUTICS COM 03152W109 3,375,126 3,487 0.10 27,541 -13.28 0.0041
2025-02-14 2024-12-31 13F AMICUS THERAPEUTICS COM 03152W109 3,371,639 187,652 5.89 31,761 -6.60 0.0045
2024-11-13 2024-09-30 13F AMICUS THERAPEUTICS COM 03152W109 3,183,987 136,633 4.48 34,005 12.49 0.0056
2024-08-14 2024-06-30 13F AMICUS THERAPEUTICS COM 03152W109 3,047,354 -108,728 -3.45 30,230 -18.69 0.0051
2024-05-14 2024-03-31 13F AMICUS THERAPEUTICS COM 03152W109 3,156,082 311,331 10.94 37,179 -7.90 0.0064
2024-02-13 2023-12-31 13F AMICUS THERAPEUTICS COM 03152W109 2,844,751 12,821 0.45 40,367 17.22 0.0073
2023-11-13 2023-09-30 13F AMICUS THERAPEUTICS COM 03152W109 2,831,930 15,608 0.55 34,436 -2.65 0.0067
2023-08-11 2023-06-30 13F AMICUS THERAPEUTICS COM 03152W109 2,816,322 99,488 3.66 35,373 17.41 0.0068
2023-05-15 2023-03-31 13F AMICUS THERAPEUTICS COM 03152W109 2,716,834 19,261 0.71 30,130 -8.53 0.0060
2023-02-13 2022-12-31 13F AMICUS THERAPEUTICS COM 03152W109 2,697,573 33,885 1.27 32,937 18.44 0.0069
2022-11-14 2022-09-30 13F AMICUS THERAPEUTICS COM 03152W109 2,663,688 -30,413 -1.13 27,809 -3.89 0.0064
2022-08-12 2022-06-30 13F AMICUS THERAPEUTICS COM 03152W109 2,694,101 5,461 0.20 28,934 13.64 0.0062
2022-05-13 2022-03-31 13F AMICUS THERAPEUTICS COM 03152W109 2,688,640 -106,397 -3.81 25,461 -21.13 0.0045
2022-02-08 2021-12-31 13F AMICUS THERAPEUTICS COM 03152W109 2,795,037 -35,963 -1.27 32,283 19.41 0.0053
2021-11-15 2021-09-30 13F AMICUS THERAPEUTICS COM 03152W109 2,831,000 -124,285 -4.21 27,036 -5.10 0.0048
2021-08-13 2021-06-30 13F AMICUS THERAPEUTICS COM 03152W109 2,955,285 -5,431 -0.18 28,489 -2.61 0.0050
2021-05-12 2021-03-31 13F AMICUS THERAPEUTICS COM 03152W109 2,960,716 -265,189 -8.22 29,253 -60.73 0.0054
2021-02-11 2020-12-31 13F AMICUS THERAPEUTICS COM 03152W109 3,225,905 -78,592 -2.38 74,486 59.64 0.0145
2020-11-16 2020-09-30 13F AMICUS THERAPEUTICS COM 03152W109 3,304,497 -205,250 -5.85 46,659 -11.84 0.0102
2020-08-14 2020-06-30 13F AMICUS THERAPEUTICS COM 03152W109 3,509,747 142,231 4.22 52,928 70.10 0.0125
2020-05-14 2020-03-31 13F AMICUS THERAPEUTICS COM 03152W109 3,367,516 38,667 1.16 31,115 -4.04 0.0089
2020-02-14 2019-12-31 13F AMICUS THERAPEUTICS COM 03152W109 3,328,849 70,440 2.16 32,424 24.08 0.0073
2019-11-13 2019-09-30 13F AMICUS THERAPEUTICS COM 03152W109 3,258,409 598,798 22.51 26,131 -21.27 0.0063
2019-08-13 2019-06-30 13F AMICUS THERAPEUTICS COM 03152W109 2,659,611 136,521 5.41 33,192 -3.27 0.0079
2019-05-13 2019-03-31 13F AMICUS THERAPEUTICS COM 03152W109 2,523,090 80,700 3.30 34,314 46.65 0.0085
2019-02-12 2018-12-31 13F AMICUS THERAPEUTICS COM 03152W109 2,442,390 -3,487 -0.14 23,398 -20.88 0.0066
2018-11-14 2018-09-30 13F AMICUS THERAPEUTICS COM 03152W109 2,445,877 51,387 2.15 29,571 -20.94 0.0072
2018-09-18 2018-06-30 13F/A-1 AMICUS THERAPEUTICS COM 03152W109 2,394,490 203,444 9.29 37,401 13.50 0.0095
2018-08-14 2018-06-30 13F AMICUS THERAPEUTICS COM 03152W109 2,406,106 215,060 37,583
2018-05-09 2018-03-31 13F AMICUS THERAPEUTICS COM 03152W109 2,191,046 219,558 11.14 32,953 16.16 0.0086
2018-02-14 2017-12-31 13F AMICUS THERAPEUTICS COM 03152W109 1,971,488 -5,371 -0.27 28,369 -4.84 0.0072
2017-11-13 2017-09-30 13F AMICUS THERAPEUTICS COM 03152W109 1,976,859 238,849 13.74 29,812 70.33 0.0078
2017-08-11 2017-06-30 13F AMICUS THERAPEUTICS COM 03152W109 1,738,010 52,569 3.12 17,502 45.64 0.0049
2017-05-12 2017-03-31 13F AMICUS THERAPEUTICS COM 03152W109 1,685,441 71,599 4.44 12,017 49.82 0.0035
2017-02-13 2016-12-31 13F AMICUS THERAPEUTICS COM 03152W109 1,613,842 13,726 0.86 8,021 -32.26 0.0025
2016-11-09 2016-09-30 13F AMICUS THERAPEUTICS COM 03152W109 1,600,116 164,436 11.45 11,841 51.05 0.0037
2016-08-12 2016-06-30 13F AMICUS THERAPEUTICS COM 03152W109 1,435,680 118,138 8.97 7,839 -29.59 0.0025
2016-08-19 2016-03-31 13F/A-1 AMICUS THERAPEUTICS COM 03152W109 1,317,542 19,034 1.47 11,134 -11.60 0.0037
2016-05-13 2016-03-31 13F AMICUS THERAPEUTICS COM 03152W109 1,317,542 11,134
2016-02-12 2015-12-31 13F AMICUS THERAPEUTICS COM 03152W109 1,298,508 34,967 2.77 12,595 -28.75 0.0042
2015-11-12 2015-09-30 13F AMICUS THERAPEUTICS COM 03152W109 1,263,541 1,019,446 417.64 17,677 411.78 0.0059
2015-08-13 2015-06-30 13F AMICUS THERAPEUTICS COM 03152W109 244,095 78,941 47.80 3,454 92.21 0.0023
2015-05-14 2015-03-31 13F AMICUS THERAPEUTICS COM 03152W109 165,154 18,149 12.35 1,797 46.93 0.0005
2015-02-12 2014-12-31 13F AMICUS THERAPEUTICS COM 03152W109 147,005 58,347 65.81 1,223 131.63 0.0004
2014-11-13 2014-09-30 13F AMICUS THERAPEUTICS COM 03152W109 88,658 -236,266 -72.71 528 -51.38 0.0002
2014-08-14 2014-06-30 13F AMICUS THERAPEUTICS COM 03152W109 324,924 -76,526 -19.06 1,086 30.69 0.0003
2014-05-14 2014-03-31 13F AMICUS THERAPEUTICS COM 03152W109 401,450 -25,142 -5.89 831 -17.15 0.0003
2014-02-21 2013-12-31 13F/A-1 AMICUS THERAPEUTICS COM 03152W109 426,592 4,358 1.03 1,003 2.45 0.0003
2014-02-12 2013-12-31 13F AMICUS THERAPEUTICS COM 03152W109 426,592 1,003
2013-11-13 2013-09-30 13F AMICUS THERAPEUTICS COM 03152W109 422,234 -4,264 -1.00 979 -1.41 0.0003
2013-08-09 2013-06-30 13F AMICUS THERAPEUTICS COM 03152W109 426,498 426,498 993 0.0004
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.